Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.

NCT01858649 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

PROCEDURE: Metastases resection
DRUG: Bevacizumab
DRUG: 5 FU
DRUG: Oxaliplatin
DRUG: Irinotecan

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Collaborators

[object Object]